$MU
Micron Technology Inc Stock $mu

$mu Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000072312515000010 Filed on January 09, 2015

Income Statement

Concept	2014 Q4	2013 Q4
Revenue	$4.573B	$4.042B
YoY Change	13.14%	120.39%
Cost Of Revenue	$2.935B	$2.761B
YoY Change	6.3%	70.75%
Gross Profit	$1.638B	$1.281B
YoY Change	27.87%	490.32%
Gross Profit Margin	35.82%	31.69%
Selling, General & Admin	$193.0M	$176.0M
YoY Change	9.66%	47.9%
% of Gross Profit	11.78%	13.74%
Research & Development	$376.0M	$320.0M
YoY Change	17.5%	42.86%
% of Gross Profit	22.95%	24.98%
Depreciation & Amortization	$643.0M	$468.0M
YoY Change	37.39%	2.41%
% of Gross Profit	39.26%	36.53%
Operating Expenses	$559.0M	$496.0M
YoY Change	12.7%	44.61%
Operating Profit	$1.079B	$551.0M
YoY Change	95.83%	-668.04%
Interest Expense	-$104.0M	$101.0M
YoY Change	-202.97%	77.19%
% of Operating Profit	-9.64%	18.33%
Other Income/Expense, Net	$2.000M	-$80.00M
YoY Change	-102.5%	35.59%
Pretax Income	$953.0M	$375.0M
YoY Change	154.13%	-278.57%
Income Tax	$75.00M	$80.00M
% Of Pretax Income	7.87%	21.33%
Net Earnings	$1.003B	$358.0M
YoY Change	180.17%	-230.18%
Net Earnings / Revenue	21.93%	8.86%
Basic Earnings Per Share		$0.34
Diluted Earnings Per Share	$839.3K	$0.30
COMMON SHARES
Basic Shares Outstanding	1.073B shares	1.046B shares
Diluted Shares Outstanding		1.196B shares

Balance Sheet

Concept	2014 Q4	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.230B	$3.870B
YoY Change	9.3%	70.41%
Cash & Equivalents	$3.764B	$3.654B
Short-Term Investments	$466.0M	$216.0M
Other Short-Term Assets	$331.0M	$207.0M
YoY Change	59.9%	179.73%
Inventory	$2.448B	$2.459B
Prepaid Expenses
Receivables	$2.301B	$2.533B
Other Receivables	$362.0M	$300.0M
Total Short-Term Assets	$9.672B	$9.369B
YoY Change	3.23%	76.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.132B	$7.733B
YoY Change	18.09%	7.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.080B	$490.0M
YoY Change	120.41%	42.86%
Other Assets	$446.0M	$494.0M
YoY Change	-9.72%	52.47%
Total Long-Term Assets	$12.87B	$10.43B
YoY Change	23.45%	19.12%
TOTAL ASSETS
Total Short-Term Assets	$9.672B	$9.369B
Total Long-Term Assets	$12.87B	$10.43B
Total Assets	$22.54B	$19.79B
YoY Change	13.88%	40.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$961.0M	$1.164B
YoY Change	-17.44%	41.09%
Accrued Expenses	$364.0M	$337.0M
YoY Change	8.01%	-26.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.168B	$1.543B
YoY Change	-24.3%	480.08%
Total Short-Term Liabilities	$4.419B	$4.513B
YoY Change	-2.08%	111.09%
LONG-TERM LIABILITIES
Long-Term Debt	$4.661B	$4.260B
YoY Change	9.41%	34.43%
Other Long-Term Liabilities	$969.0M	$875.0M
YoY Change	10.74%	52.44%
Total Long-Term Liabilities	$969.0M	$875.0M
YoY Change	10.74%	-76.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.419B	$4.513B
Total Long-Term Liabilities	$969.0M	$875.0M
Total Liabilities	$9.996B	$9.648B
YoY Change	3.61%	64.05%
SHAREHOLDERS EQUITY
Retained Earnings	$3.713B	$126.0M
YoY Change	2846.83%	-107.51%
Common Stock	$7.930B	$9.025B
YoY Change	-12.13%	-0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.68B	$9.219B
YoY Change
Total Liabilities & Shareholders Equity	$22.54B	$19.79B
YoY Change	13.88%	40.71%

Cashflow Statement

Concept	2014 Q4	2013 Q4
OPERATING ACTIVITIES
Net Income	$1.003B	$358.0M
YoY Change	180.17%	-230.18%
Depreciation, Depletion And Amortization	$643.0M	$468.0M
YoY Change	37.39%	2.41%
Cash From Operating Activities	$1.592B	$1.507B
YoY Change	5.64%	538.56%
INVESTING ACTIVITIES
Capital Expenditures	-$669.0M	$669.0M
YoY Change	-200.0%	54.15%
Acquisitions
YoY Change
Other Investing Activities	-$407.0M	-$29.00M
YoY Change	1303.45%	866.67%
Cash From Investing Activities	-$1.076B	-$122.0M
YoY Change	781.97%	-80.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$42.00M
YoY Change		2000.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-806.0M	-592.0M
YoY Change	36.15%	-1386.96%
NET CHANGE
Cash From Operating Activities	1.592B	1.507B
Cash From Investing Activities	-1.076B	-122.0M
Cash From Financing Activities	-806.0M	-592.0M
Net Change In Cash	-290.0M	793.0M
YoY Change	-136.57%	-322.13%
FREE CASH FLOW
Cash From Operating Activities	$1.592B	$1.507B
Capital Expenditures	-$669.0M	$669.0M
Free Cash Flow	$2.261B	$838.0M
YoY Change	169.81%	-523.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2864000000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2965000000	USD
CY2014Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	281000000	USD
CY2014Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	288000000	USD
CY2014Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	489000000	USD
CY2014Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	673000000	USD
CY2014Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	996000000	USD
CY2014Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	961000000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2301000000	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2524000000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15217000000	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14750000000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	35000000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	56000000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7822000000	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7879000000	USD
CY2013Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	50000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	38000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000000	USD
CY2013Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23000000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9000000	shares
CY2013Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38000000	shares
CY2014Q4	us-gaap	Assets Assets	22542000000	USD
CY2014Q3	us-gaap	Assets Assets	22498000000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	10245000000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	9672000000	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2935000000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	3000000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	384000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	466000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1057000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	866000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2999000000	USD
CY2014Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	819000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1077000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3764000000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4150000000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2880000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3654000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-386000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	774000000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1073000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1075000000	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1073000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1075000000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	108000000	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	107000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	982000000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	363000000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	23000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	981000000	USD
CY2013Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	386000000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2935000000	USD
CY2013Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2761000000	USD
CY2014Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	98000000	USD
CY2014Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	110000000	USD
CY2014Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	6593000000	USD
CY2014Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	5776000000	USD
CY2014Q4	us-gaap	Debt Current DebtCurrent	1168000000	USD
CY2014Q3	us-gaap	Debt Current DebtCurrent	1638000000	USD
	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	-518000000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	309000000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	286000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	685000000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	816000000	USD
CY2013Q4	us-gaap	Depreciation Depreciation	468000000	USD
	us-gaap	Depreciation Depreciation	613000000	USD
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09 – </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP.  The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract.  This ASU will be effective for us in our first quarter of 2018.  Early adoption is not permitted. The ASU allows for either full retrospective or modified retrospective adoption. We are evaluating the transition method that will be elected and the effects of the adoption of this ASU on our financial statements.</font></div></div>
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.94
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.84
CY2013Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-19000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-96000000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	364000000	USD
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	456000000	USD
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	305000000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	1080000000	USD
CY2014Q3	us-gaap	Equity Method Investments EquityMethodInvestments	971000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	342000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	365000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	115000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	31000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	79000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	90000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	101000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	815000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	810000000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	468000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	450000000	USD
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal year 2015 contains 53 weeks and the first quarter of fiscal 2015, which ended on December 4, 2014, contained 14 weeks. Fiscal year 2014 contained 52 weeks and the first quarter of fiscal 2014, which ended on November 28, 2013, contained 13 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 28, 2014.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2014Q4	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	5000000	USD
CY2013Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6000000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-21000000	USD
CY2013Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8000000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6000000	USD
CY2013Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-233000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-30000000	USD
CY2013Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-86000000	USD
	us-gaap	Gross Profit GrossProfit	1638000000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	1281000000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	375000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	953000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	124000000	USD
CY2013Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	86000000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000000	USD
CY2013Q4	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	76000000	USD
	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	140000000	USD
	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.12
CY2013Q4	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.06
CY2014Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	61000000	USD
CY2014Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	104000000	USD
CY2013Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-59000000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-126000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7000000	USD
CY2013Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-190000000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-321000000	USD
CY2013Q4	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	620000000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-12000000	USD
CY2013Q4	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	186000000	USD
CY2013Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	494000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-252000000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2013Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-556000000	USD
	us-gaap	Interest Expense InterestExpense	90000000	USD
CY2013Q4	us-gaap	Interest Expense InterestExpense	101000000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	916000000	USD
CY2014Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	898000000	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	2455000000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	2448000000	USD
CY2014Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	185000000	USD
CY2014Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	207000000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1325000000	USD
CY2014Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1372000000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	7000000	USD
CY2013Q4	us-gaap	Investment Income Net InvestmentIncomeNet	5000000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	10868000000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	9996000000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22498000000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22542000000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4419000000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4811000000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4608000000	USD
CY2014Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4955000000	USD
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Patent Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc.  On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed.  On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) Granting Recognition of the Japanese Reorganization Plan of MMJ and the Tokyo District Court's Confirmation Orders, (2) Entrusting MMJ's U.S. Assets to Foreign Representatives and Approving Certain Plan Transactions, (3) Granting Permanent Injunction, and (4) Granting Related Relief (the "Recognition Order").  Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">inter-partes</font><font style="font-family:inherit;font-size:10pt;"> review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing on December 9, 2013 in connection with the three petitions. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials, Inc. infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial currently is scheduled for August 21, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against us in the U.S. District Court for the District of Delaware.  The complaint alleges that a variety of our NAND Flash products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Antitrust Matters</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Securities Matters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 12, 2013, seven former shareholders of Elpida (now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of MMJ as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of MMJ and deceive shareholders prior to MMJ filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss.  The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Qimonda</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against MTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following a series of hearings with pleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments:  (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda’s claims against MTI for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things:  (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for April 24, 2015.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or equivalent monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition.  As of December 4, 2014, the Inotera Shares had a carrying value in equity method investments for purposes of our financial reporting of $568 million and a market value of $1.86 billion.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition.</font></div></div>
CY2014Q4	us-gaap	Minority Interest MinorityInterest	815000000	USD
CY2014Q3	us-gaap	Minority Interest MinorityInterest	802000000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6000000	USD
CY2013Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-806000000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-592000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1076000000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-122000000	USD
CY2013Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1507000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1592000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1003000000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	358000000	USD
CY2013Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	1002000000	USD
CY2013Q4	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	358000000	USD
CY2013Q4	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	49000000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	20000000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	551000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1085000000	USD
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	350000000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	331000000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	446000000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	497000000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1000000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-8000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-16000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-2000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-24000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21000000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-19000000	USD
CY2013Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	10000000	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1102000000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	969000000	USD
CY2013Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-80000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-49000000	USD
CY2013Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2000000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-84000000	USD
CY2013Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-234000000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	16000000	USD
CY2014Q3	us-gaap	Other Receivables OtherReceivables	278000000	USD
CY2014Q4	us-gaap	Other Receivables OtherReceivables	301000000	USD
CY2013Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-29000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	3000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	26000000	USD
CY2013Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42000000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	668000000	USD
CY2013Q4	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	196000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	669000000	USD
CY2013Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	669000000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to current period presentation. In addition, amounts for certain equipment purchases were reclassified from financing to investing within the statement of cash flows to better reflect the current nature of these transactions and to improve comparability with our industry peers.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2013Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	144000000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	18000000	USD
CY2013Q4	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	49000000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	20000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-32000000	USD
CY2013Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	330000000	USD
CY2013Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	162000000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	233000000	USD
CY2013Q4	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	113000000	USD
	us-gaap	Profit Loss ProfitLoss	1002000000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	381000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24349000000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23432000000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8682000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9132000000	USD
CY2014Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	2906000000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2663000000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	3000000	USD
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	786000000	USD
CY2013Q4	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	737000000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	376000000	USD
CY2013Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320000000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3713000000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2729000000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	4042000000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	4573000000	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11573000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12493000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	193000000	USD
CY2013Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	35000000	USD
CY2013Q4	us-gaap	Share Based Compensation ShareBasedCompensation	22000000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	154000000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	95000000	shares
CY2014Q4	us-gaap	Share Price SharePrice	36.07
CY2014Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Lower Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeLowerBound	0	USD
CY2014Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	80000000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	10771000000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	11678000000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10146000000	USD
CY2013Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10006000000	USD
CY2013Q4	us-gaap	Stockholders Equity Other StockholdersEquityOther	286000000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	75000000	USD
CY2014Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	71000000	USD
CY2014Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	89000000	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	125000000	shares
CY2013Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	150000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1195000000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1196000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1070000000	shares
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1046000000	shares
CY2014Q4	mu	Available For Sale Securities Debt Maturities After Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsFairValue	47000000	USD
CY2014Q4	mu	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	562000000	USD
CY2014Q4	mu	Available For Sale Securities Debt Maturities After Two Through Four Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFourYearsFairValue	467000000	USD
CY2014Q4	mu	Convertible Debt Equity ConvertibleDebtEquity	53000000	USD
CY2014Q3	mu	Convertible Debt Equity ConvertibleDebtEquity	57000000	USD
CY2013Q4	mu	Debt Exchange Convertible Debt Face Amount DebtExchangeConvertibleDebtFaceAmount	756000000	USD
	mu	Debt Exchange Convertible Debt Face Amount DebtExchangeConvertibleDebtFaceAmount	0	USD
	mu	Debt Instrument Increase Decrease Net Equity Component DebtInstrumentIncreaseDecreaseNetEquityComponent	-106000000	USD
	mu	Debt Instrument Increase Decrease Net Principal DebtInstrumentIncreaseDecreaseNetPrincipal	-277000000	USD
	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	643000000	USD
CY2013Q4	mu	Depreciationand Amortizationof Intangible Assets DepreciationandAmortizationofIntangibleAssets	491000000	USD
CY2013Q4	mu	Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects	0	USD
	mu	Dilutive Securities Effecton Basic Earnings Per Share Equity Method Dilutive Effects DilutiveSecuritiesEffectonBasicEarningsPerShareEquityMethodDilutiveEffects	-1000000	USD
CY2014Q3	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	289000000	USD
CY2014Q4	mu	Equipment Purchase Payable Current EquipmentPurchasePayableCurrent	664000000	USD
	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-30000000	USD
CY2013Q4	mu	Gains Losses On Extinguishment Of Debt And Derivative Gain Loss On Derivative Net GainsLossesOnExtinguishmentOfDebtAndDerivativeGainLossOnDerivativeNet	-75000000	USD
	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	2000000	USD
CY2013Q4	mu	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	1000000	USD
	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	10000000	USD
CY2013Q4	mu	Other Other Operating Income Expense Net OtherOtherOperatingIncomeExpenseNet	7000000	USD
	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	66000000	USD
CY2013Q4	mu	Payments For Derivative And Hedge Investing Activities PaymentsForDerivativeAndHedgeInvestingActivities	4000000	USD
	mu	Repaymentsto Settle Longterm Debt Obligations Gross RepaymentstoSettleLongtermDebtObligationsGross	654000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-03
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2014-12-04
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000723125
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1077313410	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MICRON TECHNOLOGY INC

Files In Submission

Name	View Source	Status
0000723125-15-000010-index-headers.html	Edgar Link	pending
0000723125-15-000010-index.html	Edgar Link	pending
0000723125-15-000010.txt	Edgar Link	pending
0000723125-15-000010-xbrl.zip	Edgar Link	pending
a2015q1.htm	Edgar Link	pending
a2015q1ex31-1ceocert.htm	Edgar Link	pending
a2015q1ex31-2cfocert.htm	Edgar Link	pending
a2015q1ex32-1906ceocert.htm	Edgar Link	pending
a2015q1ex32-2906cfocert.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mu-20141204.xml	Edgar Link	completed
mu-20141204.xsd	Edgar Link	pending
mu-20141204_cal.xml	Edgar Link	unprocessable
mu-20141204_def.xml	Edgar Link	unprocessable
mu-20141204_lab.xml	Edgar Link	unprocessable
mu-20141204_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MU
Micron Technology Inc Stock $mu

2014 Q4 Form 10-Q Financial Statement

#000072312515000010 Filed on January 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU Micron Technology Inc Stock $mu

2014 Q4 Form 10-Q Financial Statement

#000072312515000010 Filed on January 09, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MU
Micron Technology Inc Stock $mu